Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Neuroleptic treatment of late-life schizophrenia
Autore:
Salzman, C; Tune, L;
Indirizzi:
Massachusetts Mental Hlth Ctr, Dept Psychopharmacol, Boston, MA 02115 USA Massachusetts Mental Hlth Ctr Boston MA USA 02115 l, Boston, MA 02115 USA Massachusetts Mental Hlth Ctr, Dept Educ, Boston, MA 02115 USA Massachusetts Mental Hlth Ctr Boston MA USA 02115 c, Boston, MA 02115 USA Emory Univ, Dept Geriatr Psychiat, Atlanta, GA 30322 USA Emory Univ Atlanta GA USA 30322 t Geriatr Psychiat, Atlanta, GA 30322 USA Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA Harvard Univ Boston MA USA 02115 Med, Dept Psychiat, Boston, MA 02115 USA
Titolo Testata:
HARVARD REVIEW OF PSYCHIATRY
fascicolo: 2, volume: 9, anno: 2001,
pagine: 77 - 83
SICI:
1067-3229(200103/04)9:2<77:NTOLS>2.0.ZU;2-D
Fonte:
ISI
Lingua:
ENG
Soggetto:
ELDERLY PSYCHIATRIC-PATIENTS; LATE PARAPHRENIA; NURSING-HOMES; FOLLOW-UP; CLOZAPINE; PSYCHOSIS; EFFICACY; RISPERIDONE; HALOPERIDOL; REGULATIONS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Citazioni:
47
Recensione:
Indirizzi per estratti:
Indirizzo: Salzman, C Massachusetts Mental Hlth Ctr, Dept Psychopharmacol, 74 FenwoodRd, Boston, MA 02115 USA Massachusetts Mental Hlth Ctr 74 Fenwood Rd Boston MA USA 02115
Citazione:
C. Salzman e L. Tune, "Neuroleptic treatment of late-life schizophrenia", HARV R PSYC, 9(2), 2001, pp. 77-83

Abstract

There is a paucity of studies on the use of neuroleptic medication for treatment of the core symptoms of schizophrenia in elderly patients. The studies that are available have significant methodologic problems, including themixing of early- and late-onset patients, inadequate outcome criteria, andthe lack of control groups. Studies of conventional neuroleptics suggest that older patients have a moderate therapeutic response but are likely to develop side effects. The few studies of atypical antipsychotics now available suggest efficacy for treatment of behavioral disturbance in the elderly and a more favorable side-effect profile. The usefulness of all neuroleptics for the treatment of the core symptoms of late-life schizophrenia may depend on the duration and severity of the symptoms, with a poor response associated with greater severity and duration. It appears that patients with later-onset symptoms may respond better to all neuroleptics.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 09:30:49